NCT05303532: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
- State
- Under way
- Phase
- Phase 3
- People
- 214 planned
- Started
- 19 Apr 2022
- Primary completion
- 31 Dec 2026
- Arms
- Durvalumab
- Results
- None posted
- 31 Mar 2022: Trial registered
- 19 Apr 2022: Trial started